Contact Us
Prenatal And Newborn Genetic Testing Global Market Report 2025
Global Prenatal And Newborn Genetic Testing Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Prenatal And Newborn Genetic Testing Global Market Report 2025

By Product Type (Consumables, Instruments), By Screening (Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings), By Disease (Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia), By End User (Hospital, Maternity And Specialty Clinics, Diagnostic Centers) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Prenatal And Newborn Genetic Testing Market Overview

• Prenatal And Newborn Genetic Testing market size has reached to $6.68 billion in 2024

• Expected to grow to $12.07 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%

• Growth Driver: Government Initiatives Boost Growth In Prenatal And Newborn Genetic Testing Market

• Market Trend: Innovative Advances In Prenatal And Newborn Genetic Testing

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Prenatal And Newborn Genetic Testing Market?

Prenatal and newborn genetic testing refers to the medical procedures and screenings conducted during pregnancy and after birth to assess the genetic health and risk factors of both the developing fetus and the newborn baby. These tests are performed to detect and identify genetic disorders, congenital conditions, or hereditary diseases that may affect the child's health or development.

The main product types of prenatal and newborn genetic testing are consumables and instruments. Instruments are specialized tools or devices designed for performing specific tasks or measurements that include various genetic analyzers that healthcare professionals use to conduct screenings and tests. The various types of screening include non-invasive prenatal testing, chronic villus sampling, amniocentesis, maternal serum screening, and others. The various diseases include Down syndrome, phenylketonuria, Cystic Fibrosis, and sickle cell anemia. These are used by various end-users such as hospitals, maternity, and specialty clinics, and diagnostic centers.

Prenatal And Newborn Genetic Testing Market Size and growth rate 2025 to 2029: Graph

What Is The Prenatal And Newborn Genetic Testing Market Size 2025 And Growth Rate?

The prenatal and newborn genetic testing market size has grown rapidly in recent years. It will grow from $6.68 billion in 2024 to $7.6 billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to improved non-invasive prenatal testing, increased maternal age, government support and healthcare policies, patient demand for early detection.

What Is The Prenatal And Newborn Genetic Testing Market Growth Forecast?

The prenatal and newborn genetic testing market size is expected to see rapid growth in the next few years. It will grow to $12.07 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to expanded genetic test panels, increasing maternal health awareness, prenatal and newborn screening guidelines, rising focus on rare diseases, ethical and regulatory considerations. Major trends in the forecast period include non-invasive prenatal testing (NIPT), genome sequencing (WGS) and whole exome sequencing, integration of artificial intelligence (AI), preimplantation genetic testing (PGT), direct-to-consumer genetic testing.

The forecast of 12.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of non-invasive prenatal testing (NIPT) kits and newborn screening reagents sourced from South Korea and Switzerland, thereby delaying critical early diagnoses and elevating maternal-fetal medicine expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Prenatal And Newborn Genetic Testing Market Segmented?

1) By Product Type: Consumables, Instruments

2) By Screening: Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings

3) By Disease: Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia

4) By End User: Hospital, Maternity And Specialty Clinics, Diagnostic Centers

Subsegments:

1) By Consumables: Reagents And Assays, Sample Collection Kits, Test Kits

2) By Instruments: Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Analyzers

What Is Driving The Prenatal And Newborn Genetic Testing Market? Government Initiatives Boost Growth In Prenatal And Newborn Genetic Testing Market

Government initiatives and support for prenatal testing and newborn genetic screening are expected to propel the growth of the prenatal and newborn genetic testing markets going forward. Government initiatives refer to specific actions, programs, policies, or projects undertaken by a government at the local, regional, or national level to address a particular issue, achieve specific goals, or promote the well-being of its citizens. Government initiatives for prenatal and newborn genetic testing support the country's people by helping identify genetic conditions or abnormalities in fetuses during pregnancy or in newborns shortly after birth. For instance, in June 2022, the Australian government allocated $1.3 million annually to the New South Wales (NSW) ( a state on the east coast of Australia) newborn screening program to offer free tests for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA), including newborn genetic testing and screening, to all new babies in the state. The screening tests would be provided to around 100,000 babies each year, saving the lives of up to 13 newborns likely to have these genetic disorders. Therefore, government initiatives and support for prenatal testing and newborn genetic screening drive the prenatal and newborn genetic testing markets.

What Is Driving The Prenatal And Newborn Genetic Testing Market? Rising Genetic Disorder Rates Drive Prenatal And Newborn Genetic Testing Market Growth

The rising incidence of genetic disorders is expected to propel the growth of the prenatal and newborn genetic testing market going forward. Genetic disorders refer to medical conditions resulting from abnormalities or mutations in an individual's DNA or genetic material. Prenatal and newborn genetic testing can identify genetic disorders at an early stage, often before symptoms manifest, enabling healthcare providers to initiate timely interventions and treatment strategies. For instance, in May 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, sickle cell disease (SCD) affects about 100,000 people in the United States. More than 90% of those affected are non-Hispanic Black or African American, while an estimated 3%-9% are Hispanic or Latino. Therefore, the increasing prevalence of genetic disorders drives the prenatal and newborn genetic testing industry.

Who Are The Major Players In The Global Prenatal And Newborn Genetic Testing Market?

Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech PLC, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.

What Are The Key Trends Of The Global Prenatal And Newborn Genetic Testing Market? Innovative Advances In Prenatal And Newborn Genetic Testing

Major companies operating in the prenatal and newborn genetic testing markets are focusing on developing innovative screening tests, such as noninvasive prenatal screening tests, with improved accessibility and affordability to provide reliable services to customers. Noninvasive prenatal screening (NIPS), or noninvasive prenatal testing (NIPT), is a highly advanced and safe genetic screening method performed during pregnancy to assess the risk of specific fetal chromosomal abnormalities. For instance, in November 2022, Juno Diagnostics Inc., a US-based healthcare technology company, launched Juno Hazel, a noninvasive prenatal screening test that detects chromosomal aberrations and provides clinical content. The test uses a sample collection kit, eliminating the need for phlebotomy and improving accessibility. The company plans to offer educational resources and personalized genetic counseling support by partnering with physicians and genetic counselors.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Prenatal And Newborn Genetic Testing Market? CooperSurgical Partners With Fulgent Genetics To Expand Genetic Testing Services For Families Through Cord Blood Registry

In February 2024, CooperSurgical Inc., a US-based medical equipment manufacturing company, partnered with Fulgent Genetics. With this partnership, CooperSurgical aims to expand its portfolio by incorporating Fulgent Genetic's expertise in providing advanced genetic testing options for families utilizing the Cord Blood Registry. Fulgent Genetics Inc. is a US-based company that offers prenatal and newborn genetic testing.

Regional Outlook For The Global Prenatal And Newborn Genetic Testing Market

North America was the largest region in the prenatal and newborn genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Prenatal And Newborn Genetic Testing Market?

The prenatal and newborn genetic testing market consists of revenues earned by entities by providing services such as prenatal screening tests, prenatal diagnostic tests, carrier screening for genetic conditions, and newborn screening tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The prenatal and newborn genetic testing market also includes sales of electrophoresis equipment, genetic sequencing machines, and microarray analysis instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Prenatal And Newborn Genetic Testing Industry?

The prenatal and newborn genetic testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal and newborn genetic testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Prenatal And Newborn Genetic Testing Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $7.6 billion
Revenue Forecast In 2034 $12.07 billion
Growth Rate CAGR of 12.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product Type: Consumables, Instruments
2) By Screening: Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings
3) By Disease: Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia
4) By End User: Hospital, Maternity And Specialty Clinics, Diagnostic Centers Subsegments: 1) By Consumables: Reagents And Assays, Sample Collection Kits, Test Kits
2) By Instruments: Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Analyzers
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech plc, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Prenatal And Newborn Genetic Testing Market Characteristics

3. Prenatal And Newborn Genetic Testing Market Trends And Strategies

4. Prenatal And Newborn Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Prenatal And Newborn Genetic Testing Growth Analysis And Strategic Analysis Framework

5.1. Global Prenatal And Newborn Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Prenatal And Newborn Genetic Testing Market Growth Rate Analysis

5.4. Global Prenatal And Newborn Genetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Prenatal And Newborn Genetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Prenatal And Newborn Genetic Testing Total Addressable Market (TAM)

6. Prenatal And Newborn Genetic Testing Market Segmentation

6.1. Global Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Consumables

Instruments

6.2. Global Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Non-Invasive Prenatal Testing

Chronic Villus Sampling

Amniocentesis

Maternal Serum Screening

Other Screenings

6.3. Global Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Down Syndrome

Phenylketonuria

Cystic Fibrosis

Sickle Cell Anemia

6.4. Global Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital

Maternity And Specialty Clinics

Diagnostic Centers

6.5. Global Prenatal And Newborn Genetic Testing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Reagents And Assays

Sample Collection Kits

Test Kits

6.6. Global Prenatal And Newborn Genetic Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Polymerase Chain Reaction (PCR) Machines

Sequencers

Microarray Analyzers

7. Prenatal And Newborn Genetic Testing Market Regional And Country Analysis

7.1. Global Prenatal And Newborn Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Prenatal And Newborn Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prenatal And Newborn Genetic Testing Market

8.1. Asia-Pacific Prenatal And Newborn Genetic Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prenatal And Newborn Genetic Testing Market

9.1. China Prenatal And Newborn Genetic Testing Market Overview

9.2. China Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prenatal And Newborn Genetic Testing Market

10.1. India Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prenatal And Newborn Genetic Testing Market

11.1. Japan Prenatal And Newborn Genetic Testing Market Overview

11.2. Japan Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prenatal And Newborn Genetic Testing Market

12.1. Australia Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prenatal And Newborn Genetic Testing Market

13.1. Indonesia Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prenatal And Newborn Genetic Testing Market

14.1. South Korea Prenatal And Newborn Genetic Testing Market Overview

14.2. South Korea Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prenatal And Newborn Genetic Testing Market

15.1. Western Europe Prenatal And Newborn Genetic Testing Market Overview

15.2. Western Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prenatal And Newborn Genetic Testing Market

16.1. UK Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prenatal And Newborn Genetic Testing Market

17.1. Germany Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prenatal And Newborn Genetic Testing Market

18.1. France Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prenatal And Newborn Genetic Testing Market

19.1. Italy Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prenatal And Newborn Genetic Testing Market

20.1. Spain Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prenatal And Newborn Genetic Testing Market

21.1. Eastern Europe Prenatal And Newborn Genetic Testing Market Overview

21.2. Eastern Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prenatal And Newborn Genetic Testing Market

22.1. Russia Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prenatal And Newborn Genetic Testing Market

23.1. North America Prenatal And Newborn Genetic Testing Market Overview

23.2. North America Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prenatal And Newborn Genetic Testing Market

24.1. USA Prenatal And Newborn Genetic Testing Market Overview

24.2. USA Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prenatal And Newborn Genetic Testing Market

25.1. Canada Prenatal And Newborn Genetic Testing Market Overview

25.2. Canada Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prenatal And Newborn Genetic Testing Market

26.1. South America Prenatal And Newborn Genetic Testing Market Overview

26.2. South America Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prenatal And Newborn Genetic Testing Market

27.1. Brazil Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prenatal And Newborn Genetic Testing Market

28.1. Middle East Prenatal And Newborn Genetic Testing Market Overview

28.2. Middle East Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prenatal And Newborn Genetic Testing Market

29.1. Africa Prenatal And Newborn Genetic Testing Market Overview

29.2. Africa Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prenatal And Newborn Genetic Testing Market Competitive Landscape And Company Profiles

30.1. Prenatal And Newborn Genetic Testing Market Competitive Landscape

30.2. Prenatal And Newborn Genetic Testing Market Company Profiles

30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Prenatal And Newborn Genetic Testing Market Other Major And Innovative Companies

31.1. Danaher Corporation

31.2. Siemens Healthineers AG

31.3. Becton, Dickinson and Company

31.4. Quest Diagnostic Incorporated

31.5. Agilent Technologies Inc.

31.6. Grifols S.A.

31.7. Terumo Corporation

31.8. Illumina Inc.

31.9. PerkinElmer Genomics

31.10. Quidel Corporation

31.11. Bio-Rad Laboratories Inc.

31.12. Qiagen NV

31.13. Werfen S.A.

31.14. DiaSorin S.p.A

31.15. Nova Biomedical

32. Global Prenatal And Newborn Genetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prenatal And Newborn Genetic Testing Market

34. Recent Developments In The Prenatal And Newborn Genetic Testing Market

35. Prenatal And Newborn Genetic Testing Market High Potential Countries, Segments and Strategies

35.1 Prenatal And Newborn Genetic Testing Market In 2029 - Countries Offering Most New Opportunities

35.2 Prenatal And Newborn Genetic Testing Market In 2029 - Segments Offering Most New Opportunities

35.3 Prenatal And Newborn Genetic Testing Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Prenatal And Newborn Genetic Testing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Prenatal And Newborn Genetic Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Prenatal And Newborn Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Prenatal And Newborn Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: F. Hoffmann-La Roche AG Financial Performance
  • Table 78: Novartis AG Financial Performance
  • Table 79: Sanofi S.A. Financial Performance
  • Table 80: Thermo Fisher Scientific Inc. Financial Performance
  • Table 81: Abbott Laboratories Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Prenatal And Newborn Genetic Testing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Prenatal And Newborn Genetic Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Prenatal And Newborn Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Prenatal And Newborn Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: F. Hoffmann-La Roche AG Financial Performance
  • Figure 78: Novartis AG Financial Performance
  • Figure 79: Sanofi S.A. Financial Performance
  • Figure 80: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 81: Abbott Laboratories Financial Performance

Frequently Asked Questions

Prenatal and newborn genetic testing refers to the medical procedures and screenings conducted during pregnancy and after birth to assess the genetic health and risk factors of both the developing fetus and the newborn baby. These tests are performed to detect and identify genetic disorders, congenital conditions, or hereditary diseases that may affect the child's health or development. For further insights on this market, request a sample here

The market major growth driver - Government Initiatives Boost Growth In Prenatal And Newborn Genetic Testing Market. For further insights on this market, request a sample here

The prenatal and newborn genetic testing market size has grown rapidly in recent years. It will grow from $6.68 billion in 2024 to $7.6 billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to improved non-invasive prenatal testing, increased maternal age, government support and healthcare policies, patient demand for early detection. The prenatal and newborn genetic testing market size is expected to see rapid growth in the next few years. It will grow to " $12.07 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to expanded genetic test panels, increasing maternal health awareness, prenatal and newborn screening guidelines, rising focus on rare diseases, ethical and regulatory considerations. Major trends in the forecast period include non-invasive prenatal testing (NIPT), genome sequencing (WGS) and whole exome sequencing, integration of artificial intelligence (AI), preimplantation genetic testing (PGT), direct-to-consumer genetic testing. For further insights on this market, request a sample here

The prenatal and newborn genetic testingmarket covered in this report is segmented –
1) By Product Type: Consumables; Instruments
2) By Screening: Non-Invasive Prenatal Testing; Chronic Villus Sampling; Amniocentesis; Maternal Serum Screening; Other Screenings
3) By Disease: Down Syndrome; Phenylketonuria; Cystic Fibrosis; Sickle Cell Anemia
4) By End User: Hospital; Maternity And Specialty Clinics; Diagnostic Centers Subsegments:
1) By Consumables: Reagents And Assays; Sample Collection Kits; Test Kits
2) By Instruments: Polymerase Chain Reaction (PCR) Machines; Sequencers; Microarray Analyzers For further insights on this market,
request a sample here

North America was the largest region in the prenatal and newborn genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech PLC, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.. For further insights on this market, request a sample here.

Major trends in this market include Innovative Advances In Prenatal And Newborn Genetic Testing. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top